Correlation Between Panbela Therapeutics and Avalo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Panbela Therapeutics and Avalo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Panbela Therapeutics and Avalo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Panbela Therapeutics and Avalo Therapeutics, you can compare the effects of market volatilities on Panbela Therapeutics and Avalo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Panbela Therapeutics with a short position of Avalo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Panbela Therapeutics and Avalo Therapeutics.
Diversification Opportunities for Panbela Therapeutics and Avalo Therapeutics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Panbela and Avalo is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Panbela Therapeutics and Avalo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avalo Therapeutics and Panbela Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Panbela Therapeutics are associated (or correlated) with Avalo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avalo Therapeutics has no effect on the direction of Panbela Therapeutics i.e., Panbela Therapeutics and Avalo Therapeutics go up and down completely randomly.
Pair Corralation between Panbela Therapeutics and Avalo Therapeutics
Given the investment horizon of 90 days Panbela Therapeutics is expected to under-perform the Avalo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Panbela Therapeutics is 1.78 times less risky than Avalo Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Avalo Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 75,360 in Avalo Therapeutics on November 1, 2024 and sell it today you would lose (74,600) from holding Avalo Therapeutics or give up 98.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 22.92% |
Values | Daily Returns |
Panbela Therapeutics vs. Avalo Therapeutics
Performance |
Timeline |
Panbela Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Avalo Therapeutics |
Panbela Therapeutics and Avalo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Panbela Therapeutics and Avalo Therapeutics
The main advantage of trading using opposite Panbela Therapeutics and Avalo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Panbela Therapeutics position performs unexpectedly, Avalo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avalo Therapeutics will offset losses from the drop in Avalo Therapeutics' long position.Panbela Therapeutics vs. ZyVersa Therapeutics | Panbela Therapeutics vs. Sonnet Biotherapeutics Holdings | Panbela Therapeutics vs. Revelation Biosciences | Panbela Therapeutics vs. Palisade Bio |
Avalo Therapeutics vs. AnaptysBio | Avalo Therapeutics vs. Arcellx | Avalo Therapeutics vs. Structure Therapeutics American | Avalo Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Transaction History View history of all your transactions and understand their impact on performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
CEOs Directory Screen CEOs from public companies around the world |